MINDERA HEALTH
LIVE

Serial Number

97742599

Owner

Mindera Corporation

Attorney

Johnny F. Manriquez

Filing Date

Jan 5, 2023

Add to watchlist:

No watchlists yet
View on USPTO

MINDERA HEALTH Trademark

Serial Number: 97742599

MINDERA HEALTH is a trademark filed by Mindera Corporation on January 5, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Mindera Corporation

1221 Liberty Way
Vista, CA 92081

Entity Type: 03

Trademark Details

Filing Date

January 5, 2023

Registration Date

Not Registered

Goods & Services

Scientific and medical research, namely, analysis of cells, proteins and nucleic acids; Software as a service (SaaS) services and platform as a service (PaaS) featuring computer software platforms using machine-learning algorithms for collecting, storing, analyzing, sharing, reporting, and processing data in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostic research, clinical research, drug development, drug development research, drug efficacy research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Hosting an online network service in the nature of an website that enables users to store, analyze and share data in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Clinical diagnostic and consultation services for research purposes in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Computer services, namely, cloud hosting provider services and onsite provider services in the nature of technical support services, namely, installation, administration, and troubleshooting of problems for computer software for storing, analyzing and sharing information in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Providing an online network service in the nature of an website that enables users to store, access, manage, analyze and share data for use in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Database design and development; RNA analysis services for scientific research purposes involving the identification and treatment of disease; Medical research services

Filing History

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 31, 2026 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 31, 2026 RCSC
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 21, 2025 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 21, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 21, 2025 COAR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 31, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 29, 2025 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 2, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
May 2, 2024 GNSL
SUSPENSION LETTER WRITTEN
May 2, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 15, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 15, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 15, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jan 16, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jan 16, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 17, 2023 GNRN
NON-FINAL ACTION E-MAILED
Oct 17, 2023 GNRT
NON-FINAL ACTION WRITTEN
Oct 17, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 28, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jan 31, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 29, 2023 NWOS
NEW APPLICATION ENTERED
Jan 9, 2023 NWAP